Radiopharmaceuticals: A Niche But Growing Sector

2 days ago · Niche but growing market. Radiopharmaceuticals are a niche segment in the global bio/pharmaceutical market, but are showing solid growth and increased interest by the bio/pharmaceutical majors and smaller companies. The global radiopharmaceuticals market …

CouponFollow Extension

8%
OFF

Radiopharmaceuticals Market Size & Share Report, 2032

6 days from now

Jan 1, 1970 · Radiopharmaceuticals Market Size. Radiopharmaceuticals Market size was valued at USD 6.7 billion in 2023 and is anticipated to witness growth at a CAGR of 9.8% between …

gminsights.com

$3
OFF

Radiopharmaceuticals Deep-Dive: The Top Biopharma Companies …

6 days from now

Alpha-Emitter Radiopharmaceuticals are gaining significant traction within the biopharma industry, exemplified by Bristol Myers Squibb's substantial $3.6 billion acquisition of RayzeBio. This …

scitodate.com

$2
OFF

How A Radiopharma Up-and-comer Builds Momentum In A Surging …

6 days from now

Sep 17, 2024 · This year, AstraZeneca bought Fusion Pharmaceuticals for $2.4 billion, continuing the M&A trend. There were 86 deals in the radiopharmaceuticals space in the last five years, …

pharmavoice.com

FAQs about Radiopharmaceuticals: A Niche But Growing Sector Coupon?

Why is the radiopharmaceutical industry growing?

This is the mechanism behind radiopharmaceutical drugs. With a market value of $6.3 billion this year, which is forecasted to more than double over the next decade, according to a report by Statista, the radiopharmaceutical industry is growing, as more companies are becoming invested in the field. ...

Are radiopharmaceuticals the future of cancer treatment?

Emerging as a new class of drugs, radiopharmaceuticals are all the rage in cancer treatment research, at present. Pharma giant Novartis’ $1 billion acquisition of Massachusetts-based Mariana Oncology is proof of this growing fascination with this class of therapeutics. ...

Are radiopharmaceuticals a competitive area of drug research?

Right alongside Novartis is Bayer, which has also brought a radiopharmaceutical to market and is testing others. Behind them are a handful of publicly traded companies and at least a dozen biotech startups, making radiopharmaceuticals a hotly competitive area of drug research. Here’s where things stand: ...

Why are radiopharmaceuticals so important?

Targeting cancer The main driver for the interest in radiopharmaceuticals is the importance of the oncology market to the pharma industry. According to Statista, by 2027, worldwide spend on oncology will rise to $377 billion, more than double the next largest therapy area of immunology and $177 billion expenditure. ...

Are radiopharmaceuticals a good investment?

However, the long-term economic benefits often outweigh these initial expenditures. Radiopharmaceuticals, particularly in the context of nuclear medicine procedures, can provide precise and early diagnostic information, leading to more targeted and effective treatment strategies. ...

Are radiopharmaceuticals a priority for research?

Ben Hargreaves outlines how oncology is a priority for research, and how radiopharmaceuticals are one of the major new interest areas. Radiopharmaceuticals are radioisotopes that emit radiation, allowing for their precision use to destroy cancer cells. ...